Scandinavian Biopharma is pleased to inform that Christine Hägglund has been recruited as Scandinavian Biopharmas VP CMC Development. Christine holds a PhD in Biochemistry and has almost 20 years of experience in drug development of biological pharmaceuticals. Most recently, she comes from the position of Director of Analytical Science & Technology at Sobi. “I really […]
The World Vaccine Congress is on – connecting people from all over the world to discuss innovative ideas in vaccine research! Our CEO, Björn Sjöstrand, and Program Director, Catharina Forzelius, are attending, excited to network amongst vaccinologists in Washington DC.
It is with great pleasure that we present another really good year of growth. The figures for the full year 2022 add up to an increase in sales of just over SEK 28 million, equivalent to 30% in organic growth. In total, sales amount to approximately SEK 122 million. Our ETEC vaccine candidate, ETVAX, is […]
Join us when we are expanding. We are now looking for both a Senior Scientist and a Scientist with experience and interest in drug development in the late clinical phase. Join us in our work to give people worldwide a longer and better life. We are an entrepreneurial company and experts in global vaccine development, manufacturing, […]
This week, 23rd – 27th January, Scandinavian Bioharma is the guest editor for Stockholm Science City on Instagram, @sthlmscicity. Please join us, we have an exciting week in front of us! https://www.instagram.com/sthlmscicity/
After our phase 2b study in Grand Popo, Benin, we at Scandinavian Biopharma have made many friends and new contacts in this nice, but poor country. We have a special bond with the children in the orphanages in and around Grand Popo, whom we have supported in various ways in recent years. Through our friends […]
